Calls Now Open
2027 Scholar-Innovator and ADDF-Harrington
May 12, 2026
May 12, 2026, CLEVELAND, Ohio - Harrington Discovery Institute at University Hospitals in Cleveland, Ohio, today announced the 2026 class of Harrington Scholar-Innovators. The scholar awards will support breakthrough new treatments for common and rare diseases, including cardiovascular, inflammatory, hematologic, and oncologic...
Continue Reading
May 06, 2026
Benefiting patients worldwide, funding accelerates chronic lymphocytic leukemia research and rare cancer drug development through the Oxford-Harrington Rare Disease Centre and UH Seidman Cancer Center Continue Reading
April 21, 2026
Unique program for physician-scientists to advance promising discoveries into medicines Continue Reading
April 16, 2026
In a new episode of the podcast, , welcomes , and , for a conversation on how immune biology is transforming the field of neuroscience and accelerating the path from discovery to patient care.Dr. Anderson, Investigator at Harrington Discovery Institute and Co-Director of the —a partnership between the University of Oxford... Continue Reading
March 24, 2026
2026 Harrington Prize for Innovation in Medicine recognizes pioneering work in prostate cancer diagnosis and treatment Continue Reading
March 10, 2026
The annual Cozzarelli Prize acknowledges papers that reflect scientific excellence and originality. Continue Reading
February 28, 2026
I feel emotional thinking about how medical science has evolved to offer new hope of saving lives. Continue Reading
February 28, 2026
Harrington Scholar Dr. Diana Farmer Published in The Lancet Continue Reading
February 26, 2026
The Oxford-Harrington Rare Disease Centre (OHC) highlights its commitment to driving progress for rare disease—impacting the lives of families like Cynthia Schulz and her daughter Noni who spent decades living answers or effective treatments for CASK Continue Reading
February 06, 2026
Harrington Discovery Institute at University Hospitals is supporting the development of a new drug called Zalunfiban that helped thousands of heart attack patients avoid complications in clinical trials. Continue Reading